Medicine and Dentistry
Nodular Melanoma
100%
Neoplasm
61%
Cutaneous Melanoma
35%
Tumor Progression
33%
Uveal Melanoma
28%
Leptin
28%
Nevus Sebaceous
23%
Immunotherapy
17%
Next Generation Sequencing
17%
Immunohistochemistry
14%
Blood Clotting Factor 8
14%
Sentinel Lymph Node Metastasis
14%
Scatter Factor
14%
COVID-19
14%
Thyrotropin
14%
Sentinel Lymph Node Biopsy
14%
Purpuric Rash
14%
Breast Cancer
14%
Epidermal Growth Factor
14%
Gene Mutation
14%
Somatomedin C
14%
Cyclin D1
14%
Polymerase Chain Reaction
14%
Disease Exacerbation
14%
Metastatic Uvea Melanoma
14%
Reverse Transcription Polymerase Chain Reaction
14%
AT Rich Sequence
14%
Hair Follicle
14%
Dendritic Cell
14%
Central Nervous System Metastasis
14%
Mutational Load
14%
Clinical Trial
12%
Sentinel Lymph Node
11%
Abiraterone Acetate
10%
Fluorescence in Situ Hybridization
10%
Medicine
9%
Disease Free Survival
9%
Venous Ulcer
9%
Clark's Level
9%
Dermatoscopy
8%
Metastatic Carcinoma
8%
Survival Time
8%
Sentinel Node
7%
Chromosome 8q
7%
Diagnosis
6%
Melanocytic Nevus
6%
Kaplan Meier Method
5%
Malignant Neoplasm
5%
Keyphrases
Melanoma Cells
29%
Malignant Melanoma
28%
CD10
28%
Melanoma
25%
Tumor Progression
22%
Metastatic Melanoma
21%
Unfavorable Prognosis
15%
CD10 Expression
15%
Breslow Thickness
14%
MFG-E8
14%
Single-center Analysis
14%
Hair Follicle Nevus
14%
Abiraterone Acetate
14%
Japan
14%
People Strategy
14%
CD38
14%
Endothelin-1 (ET-1)
14%
308-nm Excimer Laser
14%
PD-1 Blockade
14%
Leptin Expression
14%
Early Tumor
14%
Fibroblast Cells
14%
SARS-CoV-2 RT-qPCR
14%
Sentinel Lymph Node Biopsy
14%
Cell State
14%
NRAS-mutant Melanoma
14%
Immunosuppression
14%
Purpuric Lesions
14%
Human Keratinocytes (HaCaT)
14%
Prognostic Value
14%
Tumor Cells
14%
Metastatic Uveal Melanoma
14%
Melanoma Progression
14%
Special AT-rich Sequence-binding Protein 1
14%
Epigenetic Basis
14%
Poor Prognosis
14%
Cell Changes
14%
PCR Assay
14%
Milk Fat Globule-epidermal Growth Factor 8
14%
Tumor-infiltrating Dendritic Cells
14%
Quantitative PCR
14%
Murine Melanoma
14%
Melanoma Risk
14%
Genetic Basis
14%
Modal
14%
Tumor
13%
Clark Level
10%
Pooled Testing
9%
Disease-free Survival
9%
Tumor Site
9%
Biochemistry, Genetics and Molecular Biology
DNA Methylation
23%
Epigenetics
21%
T Cell
20%
Quantitative Reverse Transcription Polymerase Chain Reaction
18%
Genetics
17%
RNA Methylation
14%
Exome
14%
Next Generation Sequencing
14%
Transcriptome
14%
Noncoding DNA
14%
Carcinogenic Activity
14%
Fluorescence in Situ Hybridization
14%
Monosomy
14%
Protein Microarray
14%
Disomy
14%
Long Non-Coding RNA
14%
MicroRNA
14%
Cancer Cell
14%
Transcriptomics
14%
Bivalent Chromatin
14%
CD38
14%
SARS Coronavirus
14%
Polymerase Chain Reaction
14%
Cell Proliferation
14%
PRC2
14%
Tumor Progression
14%
Reprogramming
14%
Clinical Trial
11%
Gene Expression
11%
Angiogenesis
9%
PD-L1
8%
EZH2
7%
Chromosome 8q
7%
Immune Checkpoints
6%